Last reviewed · How we verify
NCT04623125
Spaced Retrieval as Treatment for Aphasia
NA trial testing Spaced Retrieval Practice in Aphasia, Acquired in 21 participants. Completed in 1 January 2022.
1 January 2022
Quick facts
| Lead sponsor | Rotman Research Institute at Baycrest |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 1 October 2020 |
| Primary completion | 1 January 2022 |
| Estimated completion | 1 January 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Spaced Retrieval Practice
Conditions studied
- Aphasia, Acquired — all drugs for Aphasia, Acquired →
- Aphasia Primary Progressive — all drugs for Aphasia Primary Progressive →
Sponsor
Rotman Research Institute at Baycrest
Who can join
Eligibility, any sex, with Aphasia, Acquired or Aphasia Primary Progressive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Spaced Repetition training has been found to be more effective than massed repetition for individuals with aphasia. This study seeks to examine the relative efficiency of three kinds of spacing for picture-naming training: traditional random presentation, non-adaptive spaced repetition, and adaptive spaced repetition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04623125
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aphasia, Acquired
Currently open trials in the same condition.
- NCT07281313 — Aphasia Physical EXercise Study: Randomized Trial · NA · recruiting
- NCT06842745 — Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia · Phase 2 · recruiting
- NCT06092814 — tACS to Enhance Language Abilities · NA · recruiting
- NCT05667480 — VR and Script Training of PWA · NA · active not recruiting
- NCT05443633 — Enhancing Language Function in Aphasia · NA · recruiting
Other Rotman Research Institute at Baycrest trials
Trials by the same sponsor.
- NCT07212504 — Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory · NA · recruiting
- NCT07212465 — Accelerated Neuromodulation of Anterior Cingulate Cortex for Depression · NA · recruiting
- NCT06095063 — dTMS for Subjective Cognitive Decline · NA · recruiting
- NCT05076045 — Effects of PSAPs on Speech Processing · NA · completed
- NCT03665831 — Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04623125 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rotman Research Institute at Baycrest
- Last refreshed: 29 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04623125.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing